Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neurology · Boucher-Neuhäuser Syndrome

Getting Answers: How Boucher-Neuhäuser is Diagnosed

At a Glance

Boucher-Neuhäuser syndrome is confirmed when testing identifies two pathogenic or likely pathogenic PNPLA6 variants on opposite gene copies. MRI, specialized retinal tests, hormone studies, and checks for treatable causes support the diagnosis, but a normal MRI does not exclude it.

Because Boucher-Neuhäuser syndrome (BNS) is so rare and its symptoms can appear years apart, the road to a formal diagnosis usually involves a deep dive by three different specialists: a neurologist, an ophthalmologist, and an endocrinologist [1][2].

The Role of Genetic Testing

Because the symptoms of BNS overlap with many other conditions, molecular testing is required. Doctors typically use:

  • Multigene Panels: These tests look at a specific list of genes known to cause balance disorders or retinal issues [3].
  • Whole Exome Sequencing (WES): This test examines the protein-coding regions of your genes. It is important to know that WES can miss some intronic, structural, or repeat-related changes, so a negative result does not completely rule out a genetic disorder [4].

To confirm BNS, doctors look for two pathogenic or likely pathogenic variants in the PNPLA6 gene [1]. Finding two variants is not sufficient if they are “variants of uncertain significance” (VUS) or if they are “in cis” (on the same copy of the gene). They must be confirmed to be in trans (on opposite copies of the gene), which often involves testing your parents. Specialized RNA studies or reanalysis may be used selectively with a genetics professional [2][5].

Advanced Imaging: MRI and Eye Exams

Since symptoms can be subtle, high-tech imaging is used to look for specific physical changes in the body.

  • Brain MRI: This imaging may show cerebellar atrophy, which is a thinning of the part of the brain that controls balance. In small cohort studies, this thinning is frequently reported, and some patients also show changes in the pituitary gland [6]. However, these imaging findings are neither strictly necessary nor sufficient on their own, and a normal MRI does not rule out BNS [3].
  • Deep-Dive Eye Exams: Standard vision tests (reading a chart) often miss early signs of BNS. Specialists use Optical Coherence Tomography (OCT) to take cross-section pictures of the retina and Electroretinography (ERG) to measure the electrical response of light-sensing cells [7][8]. These tests can find “patchy” damage even before you notice a change in your vision [7].

The Endocrine Workup

A diagnosis also requires checking how your brain communicates with your reproductive system. Doctors will measure gonadotropins (LH and FSH) and sex hormones (testosterone or estrogen) [9]. In BNS, these levels are typically low because the pituitary gland/hypothalamus isn’t sending the right signals [2]. Your doctor may also check your thyroid (TSH) and growth hormones (IGF-1) to ensure your overall endocrine health [3][10].

Distinguishing BNS from Other Conditions

Because balance and hormone issues occur in several different syndromes, your doctors must carefully evaluate other possibilities. These conditions have distinguishing tendencies, though molecular testing is often needed:

Condition Distinguishing Tendencies
Gordon Holmes Syndrome Phenotypically overlaps with BNS (and can also be caused by PNPLA6 variants) but typically lacks the retinal damage found in BNS [11][12].
Marinesco-Sjögren Syndrome Includes ataxia and hormone issues, but is often marked by early-onset cataracts and muscle weakness (myopathy) [13].
Perrault Syndrome Includes ataxia and hormone issues, but is primarily characterized by sensorineural hearing loss [13].

Ruling Out Treatable Causes

Before settling on a genetic diagnosis like BNS, it is vital to rule out acquired conditions that can mimic or contribute to balance problems [14]. Your doctor may evaluate for:

  • Nutritional Deficiencies: Low levels of Vitamin E or Vitamin B12 can contribute to ataxia [15][16].
  • Gluten Ataxia: An immune reaction to gluten can damage the cerebellum [17][18]. Note: Do not start a restrictive gluten-free diet without medical advice and clinical interpretation of celiac/gluten testing.
  • Thyroid Issues: An underactive thyroid (hypothyroidism) is a treatable cause that can contribute to walking difficulties [19].

Common questions in this guide

Which genetic test is used to diagnose Boucher-Neuhäuser syndrome?
Doctors may use a multigene panel for balance or retinal disorders, whole-exome sequencing, or both. A molecular diagnosis generally requires two pathogenic or likely pathogenic changes in the PNPLA6 gene, with one on each copy of the gene. Variants of uncertain significance do not establish the diagnosis, and a negative whole-exome result may miss some types of genetic changes.
What does it mean if PNPLA6 variants are in trans?
In trans means the two variants are on opposite copies of the PNPLA6 gene, rather than on the same copy. This arrangement is needed to confirm Boucher-Neuhäuser syndrome, while variants in cis may not explain the condition. Testing biological parents can help determine whether the variants are in trans.
Can a normal brain MRI rule out Boucher-Neuhäuser syndrome?
No. MRI may show cerebellar atrophy or changes in the pituitary gland, but these findings are not required and may be absent. MRI findings alone also cannot confirm the syndrome, so genetic, eye, and hormone evaluations remain important.
What eye tests help diagnose Boucher-Neuhäuser syndrome?
An ophthalmologist may use optical coherence tomography, or OCT, to create cross-sectional images of the retina and electroretinography, or ERG, to measure how light-sensing cells respond. These tests can detect patchy retinal damage before noticeable vision changes occur. A routine eye-chart test may miss early abnormalities.
What hormone tests are part of the BNS diagnostic workup?
Doctors usually measure LH and FSH, called gonadotropins, along with sex hormones such as testosterone or estrogen. They may also check thyroid-stimulating hormone and IGF-1 to assess broader endocrine function. In BNS, low gonadotropin and sex-hormone levels can reflect impaired signaling from the hypothalamus or pituitary gland.
What conditions and treatable problems can look like Boucher-Neuhäuser syndrome?
Doctors may compare BNS with Gordon Holmes syndrome, Marinesco-Sjögren syndrome, and Perrault syndrome because they can share balance or hormone problems. They may also check for vitamin E or B12 deficiency, gluten ataxia, and hypothyroidism because these can contribute to ataxia and may be treatable. The distinguishing features and need for molecular testing vary by condition.

Get notified when new evidence is published on Ataxia-hypogonadism-choroidal dystrophy syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Two case reports of a novel missense mutation in the PNPLA6 gene in two siblings with chorioretinal dystrophy, hypogonadotropic hypogonadism, and cerebellar ataxia.

    Liampas A, Nicolaou P, Votsi C, et al.

    Molecular biology reports 2024; (51(1)):590 doi:10.1007/s11033-024-09515-4.

    PMID: 38683245
  2. 2

    Identification of Novel Compound Heterozygous Variants of the PNPLA6 Gene in Boucher-Neuhäuser Syndrome.

    He J, Liu X, Liu L, et al.

    Frontiers in genetics 2022; (13()):810537 doi:10.3389/fgene.2022.810537.

    PMID: 35198007
  3. 3

    Multifaceted and Age-Dependent Phenotypes Associated With Biallelic PNPLA6 Gene Variants: Eight Novel Cases and Review of the Literature.

    Nanetti L, Di Bella D, Magri S, et al.

    Frontiers in neurology 2021; (12()):793547 doi:10.3389/fneur.2021.793547.

    PMID: 35069422
  4. 4

    Chorioretinal dystrophy, hypogonadotropic hypogonadism, and cerebellar ataxia: Boucher-Neuhauser syndrome due to a homozygous (c.3524C>G (p.Ser1175Cys)) variant in PNPLA6 gene.

    Doğan M, Eröz R, Öztürk E

    Ophthalmic genetics 2021; (42(3)):276-282 doi:10.1080/13816810.2021.1894461.

    PMID: 33650466
  5. 5

    Novel variants in PNPLA6 causing syndromic retinal dystrophy.

    Wu S, Sun Z, Zhu T, et al.

    Experimental eye research 2021; (202()):108327 doi:10.1016/j.exer.2020.108327.

    PMID: 33141049
  6. 6

    Splenial corpus callosum lesions in Boucher-Neuhäuser syndrome: a case series and comprehensive literature review with exploratory analysis of disease duration.

    Morita Y, Nakaya M, Kurokawa R, et al.

    Neuroradiology 2026; doi:10.1007/s00234-026-04048-y.

    PMID: 42435075
  7. 7

    Detailed retinal phenotype of Boucher-Neuhäuser syndrome associated with mutations in PNPLA6 mimicking choroideremia.

    O'Neil E, Serrano L, Scoles D, et al.

    Ophthalmic genetics 2019; (40(3)):267-275 doi:10.1080/13816810.2019.1605392.

    PMID: 31135245
  8. 8

    CHORIORETINAL CHANGES IN A GENETICALLY CONFIRMED CASE OF BOUCHER-NEUHÄUSER SYNDROME.

    DeNaro BB, Dhrami-Gavazi E, Rubaltelli DM, et al.

    Retinal cases & brief reports 2021; (15(2)):179-184 doi:10.1097/ICB.0000000000000769.

    PMID: 30015775
  9. 9

    Boucher Neuhäuser Syndrome - A rare cause of inherited hypogonadotropic hypogonadism. A case of two adult siblings with two novel mutations in PNPLA6.

    Langdahl JH, Frederiksen AL, Nguyen N, et al.

    European journal of medical genetics 2017; (60(2)):105-109 doi:10.1016/j.ejmg.2016.11.003.

    PMID: 27866050
  10. 10

    Endocrine disorders and the cerebellum: from neurodevelopmental injury to late-onset ataxia.

    Manto M, Hampe CS

    Handbook of clinical neurology 2018; (155()):353-368 doi:10.1016/B978-0-444-64189-2.00023-8.

    PMID: 29891071
  11. 11

    Different Cerebellar Ataxia Phenotypes Associated with Mutations of the PNPLA6 Gene in Brazilian Patients with Recessive Ataxias.

    Teive HAG, Camargo CHF, Sato MT, et al.

    Cerebellum (London, England) 2018; (17(3)):380-385 doi:10.1007/s12311-017-0909-y.

    PMID: 29248984
  12. 12

    A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia.

    Emekli AS, Samanci B, Şimşir G, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(4)):1535-1539 doi:10.1007/s10072-020-04869-6.

    PMID: 33210227
  13. 13

    Movement Disorders Associated with Hypogonadism.

    Gonzalez-Latapi P, Sousa M, Lang AE

    Movement disorders clinical practice 2021; (8(7)):997-1011 doi:10.1002/mdc3.13308.

    PMID: 34631935
  14. 14

    Ataxias: Hereditary, Acquired, and Reversible Etiologies.

    Lin CR, Kuo SH

    Seminars in neurology 2023; (43(1)):48-64 doi:10.1055/s-0043-1763511.

    PMID: 36828010
  15. 15

    Megaloblastic wobbliness: A reversible neurological condition.

    Panda PK, Bolia R, Shrivastava Y, et al.

    Clinical nutrition ESPEN 2021; (45()):511-513 doi:10.1016/j.clnesp.2021.06.019.

    PMID: 34620364
  16. 16

    Can vitamin B12 deficiency manifest with acute posterolateral or posterior cord syndrome?

    Pandey S, V Holla V, Rizvi I, et al.

    Spinal cord series and cases 2016; (2()):16006 doi:10.1038/scsandc.2016.6.

    PMID: 28053750
  17. 17

    Gluten-related disorders: gluten ataxia.

    Hadjivassiliou M, Sanders DD, Aeschlimann DP

    Digestive diseases (Basel, Switzerland) 2015; (33(2)):264-268 doi:10.1159/000369509.

    PMID: 25925933
  18. 18

    Effect of gluten-free diet on cerebellar MR spectroscopy in gluten ataxia.

    Hadjivassiliou M, Grünewald RA, Sanders DS, et al.

    Neurology 2017; (89(7)):705-709 doi:10.1212/WNL.0000000000004237.

    PMID: 28724585
  19. 19

    Acute cerebellar ataxia: differential diagnosis and clinical approach.

    Pedroso JL, Vale TC, Braga-Neto P, et al.

    Arquivos de neuro-psiquiatria 2019; (77(3)):184-193 doi:10.1590/0004-282X20190020.

    PMID: 30970132

This page provides general information about diagnosing Boucher-Neuhäuser syndrome and does not constitute medical advice. Your neurologist, ophthalmologist, endocrinologist, and genetics professional should interpret your individual results.